WannaCry Targets US Medical Devices

WannaCry Targets US Medical Devices

The stolen NSA hacking tool that was spread across the world over the weekend, has now infected Medical Devices in the US. It is unclear what hospitals have been affected, but it is confirmed that Bayer Medrad received two reports of their devices being hit by the ransomware.

read more

2ND ANNUAL PHARMACEUTICAL MANUFACTURING EXECUTION SYSTEMS CONFERENCE

...
See Details

6TH ANNUAL REGULATORY OPERATIONS AND SUBMISSIONS CONFERENCE

...
See Details

6TH SEMI-ANNUAL MEDICAL DEVICE SUPPLIER QUALITY CONFERENCE WEST

...
See Details

ACO LEADERSHIP AND STRATEGIC GOVERNANCE FORUM

...
See Details

Sodium Bicarbonate Shortage Postpones Hospital Treatments

Hospitals around the country have begun postponing treatments in the wake of a sodium bicarbonate shortage. The simple compound is used for patients whose blood has a higher acidity during surgical procedures, chemotherapy, and other vital treatments. Though drug shortages are down significantly from their highest of 251 in 2011, more than 50 drugs are still classified as scarce or in shortage by the FDA as of 2017. Read the full article here.

Roche Unveils Latest Diabetes Testing System and Savings Plan

Roche has unveiled its latest glucose monitoring system along with a savings plan for diabetic patients. The system, paired with a smartphone app and discounted testing strips, may help patients keep track detailed accounts of their glucose levels, which may healthcare professionals in further disease treatment. The new system also features a spill-proof vial, larger blood application area on testing strips, and a light on the testing strip for improved visibility. The savings plan aims to compete with big-box retailers by offering free discount cards available online and cheaper testing materials. Read the full press release here.

VitalConnect Collects $33 Million for VitalPatch Monitoring Sticker

VitalConnect has raised $33 million in a series C funding, which will aid in commercial development of its at-home monitoring adhesive, VitalPatch. The disposable sticker is able to monitor skin temperature, breathing rate, posture, motion (including falling), ECG, heart rate, and variability in heart rate. The patch lasts for up to four days before a replacement is needed. VitalPatch has secured biosensors as a vital step in the evolution of remote and at-home professional treatment. Read the full article here.

AstraZeneca Asthma Trial Shows Slowed Use of Steroids

AstraZeneca has released phase 3 clinical trial information linking their newest asthma medication with reduced oral steroid use in patients with severe asthmatic symptoms. The drug, benralizumab, shows a limited need for steroids, which according to an AstraZeneca statement, may cause weight gain, diabetes, anxiety, depression and osteoporosis. The FDA will be deciding the benralizumab’s approval status during the fourth quarter of 2017. The drug is also being considered in Europe and Japan among other countries. Read the full press release here.

CONTACT US
Q1 Productions
500 N. Dearborn Suite 500 | Chicago, IL 60654
Chicago, IL 60654
T: 312.822.8100
F: 312.873.3969
[email protected]

 

 

Share This